These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
398 related articles for article (PubMed ID: 33245270)
1. Recent Progress in the Drug Development for the Treatment of Alzheimer's Disease Especially on Inhibition of Amyloid-peptide Aggregation. Liu Y; Cong L; Han C; Li B; Dai R Mini Rev Med Chem; 2021; 21(8):969-990. PubMed ID: 33245270 [TBL] [Abstract][Full Text] [Related]
2. Current Strategies for Modulating Aβ Aggregation with Multifunctional Agents. Du Z; Li M; Ren J; Qu X Acc Chem Res; 2021 May; 54(9):2172-2184. PubMed ID: 33881820 [TBL] [Abstract][Full Text] [Related]
3. A new naphthalene derivative with anti-amyloidogenic activity as potential therapeutic agent for Alzheimer's disease. Rivera-Marrero S; Bencomo-Martínez A; Orta Salazar E; Sablón-Carrazana M; García-Pupo L; Zoppolo F; Arredondo F; Dapueto R; Daniela Santi M; Kreimerman I; Pardo T; Reyes L; Galán L; León-Chaviano S; Espinosa-Rodríguez LA; Menéndez-Soto Del Valle R; Savio E; Díaz Cintra S; Rodríguez-Tanty C Bioorg Med Chem; 2020 Oct; 28(20):115700. PubMed ID: 33069076 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of amyloid-β aggregation in Alzheimer's disease. Wang Q; Yu X; Li L; Zheng J Curr Pharm Des; 2014; 20(8):1223-43. PubMed ID: 23713775 [TBL] [Abstract][Full Text] [Related]
5. Synthesis, biological evaluation and molecular modeling of benzofuran piperidine derivatives as Aβ antiaggregant. Chowdhury SR; Gu J; Hu Y; Wang J; Lei S; Tavallaie MS; Lam C; Lu D; Jiang F; Fu L Eur J Med Chem; 2021 Oct; 222():113541. PubMed ID: 34116326 [TBL] [Abstract][Full Text] [Related]
6. Synthetic Curcumin Analogs as Inhibitors of β -Amyloid Peptide Aggregation: Potential Therapeutic and Diagnostic Agents for Alzheimer's Disease. Bukhari SN; Jantan I Mini Rev Med Chem; 2015; 15(13):1110-21. PubMed ID: 26420724 [TBL] [Abstract][Full Text] [Related]
7. β-sheet interfering molecules acting against β-amyloid aggregation and fibrillogenesis. Francioso A; Punzi P; Boffi A; Lori C; Martire S; Giordano C; D'Erme M; Mosca L Bioorg Med Chem; 2015 Apr; 23(8):1671-83. PubMed ID: 25769517 [TBL] [Abstract][Full Text] [Related]
8. Mechanistic Insight into the Design of Chemical Tools to Control Multiple Pathogenic Features in Alzheimer's Disease. Han J; Du Z; Lim MH Acc Chem Res; 2021 Oct; 54(20):3930-3940. PubMed ID: 34606227 [TBL] [Abstract][Full Text] [Related]
9. The Pathogenesis Mechanism, Structure Properties, Potential Drugs and Therapeutic Nanoparticles against the Small Oligomers of Amyloid-β. Wang K; Na L; Duan M Curr Top Med Chem; 2021; 21(2):151-167. PubMed ID: 32938351 [TBL] [Abstract][Full Text] [Related]
10. Semi-synthesis and biological evaluation of flavone hybrids as multifunctional agents for the potential treatment of Alzheimer's disease. Shi S; Wang H; Wang J; Wang Y; Xue X; Hou Z; Yao GD; Huang XX; Zhao H; Liu Q; Song SJ Bioorg Chem; 2020 Jul; 100():103917. PubMed ID: 32442817 [TBL] [Abstract][Full Text] [Related]
11. Exploring the potential of pyrazoline containing molecules as Aβ aggregation inhibitors in Alzheimer's disease. Khambete MP; Khare LP; Kapadia AB; Degani MS Drug Metab Pers Ther; 2020 Aug; 35(3):. PubMed ID: 32776895 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of Aβ aggregates in Alzheimer's disease by epigallocatechin and epicatechin-3-gallate from green tea. Chen T; Yang Y; Zhu S; Lu Y; Zhu L; Wang Y; Wang X Bioorg Chem; 2020 Dec; 105():104382. PubMed ID: 33137558 [TBL] [Abstract][Full Text] [Related]
13. Breaker peptides against amyloid-β aggregation: a potential therapeutic strategy for Alzheimer's disease. Ghosh N; Kundu LM Future Med Chem; 2021 Oct; 13(20):1767-1794. PubMed ID: 34498978 [TBL] [Abstract][Full Text] [Related]
14. N-Terminus Binding Preference for Either Tanshinone or Analogue in Both Inhibition of Amyloid Aggregation and Disaggregation of Preformed Amyloid Fibrils-Toward Introducing a Kind of Novel Anti-Alzheimer Compounds. Dong M; Zhao W; Hu D; Ai H; Kang B ACS Chem Neurosci; 2017 Jul; 8(7):1577-1588. PubMed ID: 28406293 [TBL] [Abstract][Full Text] [Related]
15. Inhibiting the Aggregation of Aβ by Natural Product Molecules. Bai SC; Wang YC; Li XZ; Li G ChemMedChem; 2024 Sep; 19(17):e202400223. PubMed ID: 38807345 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of Alzheimer's amyloid-beta aggregation in-vitro by carbenoxolone: Insight into mechanism of action. Sharma S; Nehru B; Saini A Neurochem Int; 2017 Sep; 108():481-493. PubMed ID: 28652220 [TBL] [Abstract][Full Text] [Related]
18. Fluorescent Dopamine-Tryptophan Nanocomposites as Dual-Imaging and Antiaggregation Agents: New Generation of Amyloid Theranostics with Trimeric Effects. Sharma M; Tiwari V; Shukla S; Panda JJ ACS Appl Mater Interfaces; 2020 Sep; 12(39):44180-44194. PubMed ID: 32870652 [TBL] [Abstract][Full Text] [Related]
19. An Increasing Role of Polyphenols as Novel Therapeutics for Alzheimer's: A Review. Karim N; Khan H; Khan I; Guo O; Sobarzo-Sánchez E; Rastrelli L; Kamal MA Med Chem; 2020; 16(8):1007-1021. PubMed ID: 31702507 [TBL] [Abstract][Full Text] [Related]
20. Natural Products Targeting Amyloid Beta in Alzheimer's Disease. Lee JH; Ahn NH; Choi SB; Kwon Y; Yang SH Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33652858 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]